Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients | Nature Communications
EGFR and bevacizumab in first-line KRAS wild-type tumours: randomized... | Download Scientific Diagram
RAS mutations: impact on treatment outcome | Colorectal Cancer
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study - The Lancet Oncology
Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
Targeting the untargetable KRAS in cancer therapy - ScienceDirect
Frontiers | Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Frontiers | Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
KRAS-Targeted Therapy Doubles as Component of Immunotherapy - NCI
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon -Rectal Cancer: The Case of KRAS-Mutated Tumors
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer. | Semantic Scholar
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
The current treatment paradigm for patients with metastatic colorectal... | Download Scientific Diagram
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
The Trouble With KRAS - Cancer Commons
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Colorectal Cancer – Treatments | Gastrointestinal Cancer
Frequencies of RAS/BRAFV600E mutation subtypes. N = 152 (KRAS Exon2... | Download Scientific Diagram
Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
